• Profile
Close

Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

BMC Cardiovascular Disorders Jan 24, 2019

Reichart C, et al. - Researchers compared patients with short (< 20 mm) and long (≥20 mm) coronary artery lesions in terms of long-term outcome up to 36 months after implantation of bioresorbable vascular scaffolds (BVS) with the PSP-technique (predilation, proper sizing, and postdilation). They conducted this prospective study with 326 patients who had 424 lesions. Patients underwent percutaneous coronary intervention with the Absorb BVS. Outcomes revealed significantly higher rates of device oriented composite endpoint (defined as cardiac death, myocardial infarction not clearly related to a non-target vessel and target lesion revascularization) in long lesions vs short ones when the bioresorbable scaffold Absorb was implanted with the PSP technique.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay